BeOne Medicines CEO sells ADS for tax withholding
BeOne Medicines Ltd. Chief Executive Officer John Oyler reported open‑market sales of 3,693 American Depositary Shares on June 16, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
BeOne Medicines Ltd. Chief Executive Officer John Oyler reported open‑market sales of 3,693 American Depositary Shares on June 16, 2026. The ADS were sold in three trades at weighted average prices of about $264.87 to $266.69 per ADS.
According to a footnote, these sales were executed under a mandatory tax‑withholding provision tied to the vesting of a restricted share unit award previously granted to him. After these transactions, Oyler directly holds 5,649,640 Ordinary Shares and also reports several indirect Ordinary Share holdings via trusts and an LLC, for some of which he disclaims beneficial ownership.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | American Depositary Shares | 1,650 | $264.8738 | $437K |
| Sale | American Depositary Shares | 1,710 | $265.9856 | $455K |
| Sale | American Depositary Shares | 333 | $266.6947 | $89K |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Footnotes (10)
- F1. These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
- F2. These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F3. These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
- F4. These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
- F5. These securities are held by The John Oyler Legacy Trust for the benefit of the Reporting Person's child, for which the Reporting Person disclaims beneficial ownership.
- F6. Each American Depositary Share represents 13 Ordinary Shares.
- F7. The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 15, 2023, subject to continued service. Unvested securities are subject to accelerated vesting upon change of control or certain termination events.
- F8. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $264.425 to $265.395, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F9. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $265.45 to $266.43, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F10. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $266.46 to $266.905, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
Key Figures
Key Terms
grantor retained annuity trust financial
Roth IRA financial
weighted average price financial
AI-generated analysis. How Rhea-AI works. Not financial advice.